Neuroradiologic patterns and novel imaging findings in Aicardi-Goutières syndrome

Neurology

Volumn 86, Issue 1, 2016, Pages 28-35

  La Piana, Roberta ^a   Uggetti, Carla ^b   Roncarolo, Federico ^c   Vanderver, Adeline ^d   Olivieri, Ivana ^e   Tonduti, Davide ^f,g   Helman, Guy ^d   Balottin, Umberto ^e,f   Fazzi, Elisa ^h   Crow, Yanick J ^i,j   Livingston, John ^k   Orcesi, Simona ^e  

^a MCGILL UNIVERSITY   (Canada)

^b SAN CARLO BORROMEO HOSPITAL   (Italy)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^e C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^f UNIVERSITY OF PAVIA   (Italy)

^g DEPARTMENT OF NEUROSURGERY   (Italy)

^h UNIVERSITY OF BRESCIA   (Italy)

ⁱ IMAGINE INSTITUTE   (France)

^j UNIVERSITY OF MANCHESTER   (United Kingdom)

^k LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AICARDI GOUTIERES SYNDROME; ARTICLE; BRAIN ATROPHY; BRAIN CALCIFICATION; CHILD; CLINICAL EVALUATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; FEMALE; FOLLOW UP; GENE MUTATION; GENOTYPE; HUMAN; LEUKOENCEPHALOPATHY; MAJOR CLINICAL STUDY; MALE; NEURORADIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PHENOTYPE; PRIORITY JOURNAL; WHITE MATTER; ADOLESCENT; DIAGNOSTIC IMAGING; GENETICS; INFANT; NERVOUS SYSTEM MALFORMATION; NEUROLOGIC DISEASE; NEWBORN; PRESCHOOL CHILD; X-RAY COMPUTED TOMOGRAPHY; YOUNG ADULT;

EXODEOXYRIBONUCLEASE; PHOSPHOPROTEIN; THREE PRIME REPAIR EXONUCLEASE 1;

ADOLESCENT; AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM; CHILD; CHILD, PRESCHOOL; EXODEOXYRIBONUCLEASES; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MAGNETIC RESONANCE IMAGING; MALE; NERVOUS SYSTEM MALFORMATIONS; PHOSPHOPROTEINS; TOMOGRAPHY, X-RAY COMPUTED; WHITE MATTER; YOUNG ADULT;

EID: 84952334342     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000002228     Document Type: Article

References (33)

1. Crow YJ, Hayward BE, Parmar R, et al. Mutations in the gene encoding the 39-59 DNA exonuclease TREX1 cause Aicardi-Goutières syndrome at the AGS1 locus. Nat Genet 2006; 38: 917-920
2. Crow YJ, Leitch A, Hayward BE, et al. Mutations in genes encoding ribonuclease H2 subunits cause Aicardi-Goutieres syndrome and mimic congenital viral brain infection. Nat Genet 2006; 38: 910-916
3. Rice GI, Bond J, Asipu A, et al. Mutations involved in Aicardi-Goutieres syndrome implicate SAMHD1 as regulator of the innate immune response. Nat Genet 2009; 41: 829-832
4. Rice GI, Kasher PR, Forte GM, et al. Mutations in ADAR1 cause Aicardi-Goutieres syndrome associated with a type I interferon signature. Nat Genet 2012; 44: 1243-1248
5. Rice GI, del Toro Duany Y, Jenkinson EM, et al. Gain-offunction mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling. Nat Genet 2014; 46: 503-509
6. Lanzi G, Fazzi E, DArrigo S, et al. The natural history of Aicardi-Goutieres syndrome: follow-up of 11 Italian patients. Neurology 2005; 64: 1621-1624
7. Aicardi J, Goutieres F. A progressive familial encephalopathy in infancy with calcifications of the basal ganglia and chronic cerebrospinal fluid lymphocytosis. Ann Neurol 1984; 15: 49-54
8. Lanzi G, Fazzi E, DArrigo S. Aicardi-Goutieres syndrome: a description of 21 new cases and a comparison with the literature. Eur J Paediatr Neurol 2002; 6(suppl A): A9-A22; discussion A23-25, A77-A86
9. Crow YJ, Livingston JH. Aicardi-Goutieres syndrome: an important Mendelian mimic of congenital infection. Dev Med Child Neurol 2008; 50: 410-416
10. Crow YJ, Chase DS, Lowenstein Schmidt J, et al. Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1. Am J Med Genet A 2015; 167: 296-312
11. Orcesi S, La Piana R, Fazzi E. Aicardi-Goutières syndrome. Br Med Bull 2009; 89: 183-201
12. Orcesi S, Pessagno A, Biancheri R, et al. Aicardi-Goutieres syndrome presenting atypically as a sub-acute leukoencephalopathy. Eur J Paediatr Neurol 2008; 12: 408-411
13. DArrigo S, Riva D, Bulgheroni S, et al. Aicardi-Goutieres syndrome: description of a late onset case. Dev Med Child Neurol 2008; 50: 631-634
14. La Piana R, Tran L, Guerrero K, et al. Spastic paraparesis and marked improvement of leukoencephalopathy in Aicardi-Goutières syndrome. Neuropediatrics 2014; 45: 406-410
15. Crow YJ, Zaki MS, Abdel-Hamid MS, et al. Mutations in ADAR1, IFIH1, and RNASEH2B presenting as spastic paraplegia. Neuropediatrics 2014; 45: 386-393
16. Uggetti C, La Piana R, Orcesi S, Egitto MG, Crow YJ, Fazzi E. Aicardi-Goutieres syndrome: neuroradiologic findings and follow-up. AJNR Am J Neuroradiol 2009; 30: 1971-1976
17. Livingston JH, Stivaros S, van Der Knaap MS, Crow YJ. Recognizable phenotypes associated with intracranial calcification. Dev Med Child Neurol 2013; 55: 46-57
18. Rice G, Patrick T, Parmar R, et al. Clinical and molecular phenotype of Aicardi-Goutieres syndrome. Am J Hum Genet 2007; 81: 713-725
19. Xin B, Jones S, Puffenberger EG, et al. Homozygous mutation in SAMHD1 gene causes cerebral vasculopathy and early onset stroke. Proc Natl Acad Sci USA 2011; 108: 5372-5377
20. Thiele H, du Moulin M, Barczyk K, et al. Cerebral arterial stenoses and stroke: novel features of Aicardi-Goutieres syndrome caused by the Arg164X mutation in SAMHD1 are associated with altered cytokine expression. Hum Mutat 2010; 31: E1836-E1850
21. Ramesh V, Bernardi B, Stafa A, et al. Intracerebral large artery disease in Aicardi-Goutieres syndrome implicates SAMHD1 in vascular homeostasis. Dev Med Child Neurol 2010; 52: 725-732
22. Olivieri I, Cattalini M, Tonduti D, et al. Dysregulation of the immune system in Aicardi-Goutieres syndrome: another example in a TREX1-mutated patient. Lupus 2013; 22: 1064-1069
23. Livingston JH, Lin JP, Dale RC, et al. A type I interferon signature identifies bilateral striatal necrosis due to mutations in ADAR1. J Med Genet 2014; 51: 76-82
24. La Piana R, Uggetti C, Olivieri I, et al. Bilateral striatal necrosis in two subjects with Aicardi-Goutieres syndrome due to mutations in ADAR1 (AGS6). Am J Med Genet A 2014; 164A: 815-819
25. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap): a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009; 42: 377-381
26. Rice GI, Forte GM, Szynkiewicz M, et al. Assessment of interferon-related biomarkers in Aicardi-Goutieres syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study. Lancet Neurol 2013; 12: 1159-1169
27. Livingston JH, Stivaros S, Warren D, Crow YJ. Intracranial calcification in childhood: a review of aetiologies and recognizable phenotypes. Dev Med Child Neurol 2014; 56: 612-626
28. Vanderver A, Prust M, Kadom N, et al. Early-onset Aicardi-Goutieres syndrome: magnetic resonance imaging (MRI) pattern recognition. J Child Neurol 2015; 30: 1343-1348
29. Schiffmann R, van Der Knaap MS. Invited article: an MRIbased approach to the diagnosis of white matter disorders. Neurology 2009; 72: 750-759
30. Laugel V. Cockayne syndrome: the expanding clinical and mutational spectrum. Mech Ageing Dev 2013; 134: 161-170
31. Koob M, Laugel V, Durand M, et al. Neuroimaging in Cockayne syndrome. AJNR Am J Neuroradiol 2010; 31: 1623-1630
32. Henneke M, Diekmann S, Ohlenbusch A, et al. RNASET2-deficient cystic leukoencephalopathy resembles congenital cytomegalovirus brain infection. Nat Genet 2009; 41: 773-775
33. Crow YJ, Vanderver A, Orcesi S, Kuijpers TW, Rice GI. Therapies in Aicardi-Goutieres syndrome. Clin Exp Immunol 2014; 175: 1-8